(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (JJ primary) (JJ human) (NNS T-lymphocytes))) (PP (IN through) (NP (NP-COOD (NP (NN CD2)) (CC plus) (NP (NN CD28))) (NN adhesion) (NNS molecules)))) (VP (VBZ induces) (NP (NP (JJ long-term) (JJ nuclear) (NN expression)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (. .))
(S (NP-SBJ (NP (NN Stimulation)) (PP (IN of) (NP (ADJP (RB highly) (VBN purified)) (JJ human) (NNS T-cells))) (PP (IN via) (NP (NP-COOD (NP (NN CD2)) (CC and) (NP (NN CD28))) (NN adhesion) (NNS molecules)))) (VP (VP-COOD (VP (VBZ induces) (NP (-NONE- *RNR*-32))) (CC and) (VP (VBZ maintains) (NP (-NONE- *RNR*-32)) (PP (-NONE- *ICH*-33)))) (NP-32 (NN proliferation)) (PP-TMP-33 (IN for) (NP (QP (JJR more) (IN than) (CD 3)) (NNS weeks)))) (. .))
(S (NP-SBJ (DT This) (JJ potent) (ADJP (NN interleukin) (CD 2) (-LRB- -LRB-) (NN IL-2) (-RRB- -RRB-) (JJ -dependent)) (NN activation)) (VP (VBZ does) (RB not) (VP (VB require) (NP-COOD (NP (NNS monocytes)) (CC or) (NP (JJ accessory) (NNS cells))))) (. .))
(S (NP-SBJ-100 (JJ Long-lasting) (NN IL-2) (NN receptivity)) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-100)) (PP (IN with) (NP (NP (JJ high-level) (NN expression)) (PP (IN of) (NP (DT the) (JJ inducible) (NP (NP (NN IL-2) (NN receptor) (NN alpha) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-))) (NN gene))) (SBAR (WHNP-34 (WDT that)) (S (NP-SBJ-35 (-NONE- *T*-34)) (VP (VBZ is) (VP (VBN regulated) (NP (-NONE- *-35)) (PP (IN at) (NP (ADJP-COOD (CC both) (ADJP (JJ transcriptional)) (CC and) (ADJP (JJ posttranscriptional))) (NNS levels))))))))))) (. .))
(S (NP-SBJ (NP (NN Increase)) (PP (IN of) (NP (NN IL-2R) (NN alpha) (NN gene) (NN transcription)))) (VP (VBZ involves) (NP (NP (DT the) (VBN enhanced) (NN binding)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NN NF-kappa) (NN B))) (PP (TO to) (NP (NP (PRP$ its) (NN consensus) (NN sequence)) (PP (IN in) (NP (NP (DT the) (JJ 5'-regulatory) (NN region)) (PP (IN of) (NP (DT the) (NN IL-2R) (NN alpha) (NN gene))))))))) (. .))
(S (S (NP-SBJ (-NONE- *-37)) (VP (TO To) (VP (VB dissect) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN for) (NP (NP (DT the) (ADJP (RB unusually) (JJ persistent)) (NN transcription)) (PP (IN of) (NP (DT the) (NN IL-2R) (NN alpha) (NN gene))))))))) (, ,) (NP-SBJ-37 (PRP we)) (VP (VBD analyzed) (NP (NP (JJ nuclear) (NN NF-kappa) (NN B) (VBG binding)) (PP (TO to) (NP (DT a) (VBN radiolabeled) (NN IL-2R) (NN alpha) (ADJP (NN kappa) (JJ B-specific)) (NN oligonucleotide) (NN probe))) (PP-TMP (IN during) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (NP-COOD (NP (NN CD2)) (CC +) (NP (NN CD28))) (NN activation))))))) (. .))
(S (NP-SBJ (VBG Resting) (NN T-cell) (JJ nuclear) (NNS extracts)) (VP (VBD contained) (NP (NN (p50 KBF1)) (NN homodimer))) (. .))
(S (PP-TMP (IN After) (NP (NN stimulation))) (, ,) (NP-SBJ-38 (CD two) (JJ new) (ADJP (NN kappa) (JJ B-specific)) (NNS complexes)) (VP (VBD were) (VP (VBN identified) (NP (-NONE- *-38)) (PP (IN as) (NP-COOD (NP (NN NF-kappa) (NN B) (NN p50-p65) (NN heterodimer)) (CC and) (NP (JJ putative) (NP-COOD (NP (NN c-Rel) (NN homodimer)) (CC or) (NP (NN c-Rel-p65) (NN heterodimer)))))))) (. .))
(S (NP-SBJ (DT Both) (JJ inducible) (NNS complexes)) (VP (VBD persisted) (PP-TMP (IN for) (NP (QP (IN at) (JJS least) (CD 3)) (NNS weeks)))) (. .))
(S (NP-SBJ (PRP$ Their) (JJ relative) (NNS levels)) (VP (VBD were) (ADJP-PRD (RB very) (JJ similar)) (PP-TMP (IN for) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN proliferation)))))) (. .))
(S (PP (IN In) (NP (NN parallel))) (, ,) (NP-SBJ (NP-COOD (NP (NN CD2)) (CC +) (NP (NN CD28))) (NN activation)) (VP (VBD triggered) (NP (DT a) (JJ significant) (JJ intracellular) (NN thiol) (NN decrease)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-40 (NN oxygen) (NNS radicals)) (VP (VBP are) (VP (VBN involved) (NP (-NONE- *-40)) (PP (IN in) (NP (NP (DT the) (NN signaling) (NN pathway)) (PP (IN of) (NP (NN adhesion) (NNS molecules)))))))))))) (. .))
(S (ADVP-TMP (RB Finally)) (, ,) (NP-SBJ (NP (JJ micromolar) (NNS amounts)) (PP (IN of) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (, ,) (NP (NP (DT an) (ADJP (NN oxygen) (NN radical)) (NN scavenger)) (SBAR (WHNP-41 (WDT that)) (S (NP-SBJ (-NONE- *T*-41)) (ADVP (RB efficiently)) (VP (VBD blocked) (NP (NP (DT the) (JJ nuclear) (NN appearance)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NNS T-lymphocytes)))))))) (, ,)))) (ADVP (RB also)) (VP (VBD inhibited) (NP-COOD (NP (NN IL-2) (NN secretion)) (, ,) (NP (NN IL-2R) (NN alpha) (NN cell) (NN surface) (NN expression)) (, ,) (CC and) (NP (NN T-cell) (NN proliferation)))) (. .))
(S (ADVP (RB Together)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN NF-kappa) (NN B)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (JJ long-term) (NN activation)) (PP (IN of) (NP (JJ human) (JJ primary) (NNS T-lymphocytes))) (PP (IN via) (NP-COOD (NP (NN CD2)) (CC +) (NP (NN CD28)))))))))) (. .))
